Medically reviewed by Qin Rao, MD Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Are you stuck in a cycle of asthma attacks? You may have eosinophilic asthma. Find out what it is and what you can do to break the cycle.

In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...

Patients with eosinophilic asthma tend to have more severe disease ... were able to lower the prednisone dose required to control symptoms by ≥50%, the study’s primary endpoint.

Study identifies eosinophil levels as key to predicting gastrointestinal lesions in eosinophilic granulomatosis, offering a ...

Nucala (mepolizumab) is the first biologic treatment to target specific white blood cells called eosinophils, which are responsible for symptoms in thousands of asthma patients. Given by injection ...

Eosinophilic inflammation plays a role in at least half of asthma and one-third of COPD flare-ups. For these people, targeting eosinophils when symptoms worsen is a promising strategy.